Compare

Edesa Biotech, Inc. vs CalciMedica, Inc. vs Chemomab Therapeutics Ltd. vs Actuate Therapeutics, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Edesa Biotech, Inc. EDSA	CalciMedica, Inc. CALC	Chemomab Therapeutics Ltd. CMMB	Actuate Therapeutics, Inc. ACTU
Year ended	2025-09-30	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$7.19M	-$29.56M	-$8.99M	-$22.23M
EPS (Diluted)	n/a	-$1.97	$0.018	-$1.06
Operating cash flow	-$7.32M	-$21.18M	-$11.13M	-$19.21M
Free cash flow	n/a	-$21.21M	-$11.13M	n/a
Cash & equivalents	$10.80M	$11.52M	$7.56M	$13.16M
Total assets	$13.53M	$13.59M	$13.81M	$14.04M
Total liabilities	n/a	$20.23M	$1.48M	$6.11M
Shareholders' equity	$12.45M	-$6.64M	$12.33M	$7.92M
Return on year-end equity	-57.7%	n/a	-72.9%	-280.5%
Shares outstanding	7.14M	15.44M	n/a	23.25M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Edesa Biotech, Inc.	CalciMedica, Inc.	Chemomab Therapeutics Ltd.	Actuate Therapeutics, Inc.
Latest	$0 Ended 2021-09-30	n/a	n/a	n/a
1 year earlier	$328.8K Ended 2020-09-30	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	$211.8K Ended 2018-09-30	n/a	n/a	n/a
4 years earlier	$228.3K Ended 2017-09-30	n/a	n/a	n/a